Summary
Boston Scientific Corporation (BSX) filed an 8-K on October 24, 2018, to announce its third-quarter financial results for the period ended September 30, 2018. The accompanying press release, furnished as Exhibit 99.1, provides the details of the company's performance during the quarter. Investors should refer to this press release for specific financial figures and operational updates. While the 8-K itself does not contain detailed financial tables, it serves as the official notification mechanism for the release of this important information. The filing indicates that the company has met its reporting obligations regarding its quarterly performance, and all substantive details are within the referenced press release. Investors are encouraged to review Exhibit 99.1 for a comprehensive understanding of the company's financial condition and results of operations for the third quarter of 2018.
Key Highlights
- 1Boston Scientific announced its third-quarter 2018 financial results on October 24, 2018.
- 2The announcement was made via a press release furnished as Exhibit 99.1 to the 8-K filing.
- 3The filing pertains to the financial results for the quarter ended September 30, 2018.
- 4This 8-K filing is a standard disclosure mechanism for the company's quarterly performance.
- 5Investors need to consult the press release (Exhibit 99.1) for specific financial data and operational details.
- 6The information presented is not deemed 'filed' for Section 18 purposes of the Exchange Act, limiting certain liabilities.